Royal Bank of Canada
VVOS icon

Royal Bank of Canada’s Vivos Therapeutics VVOS Stock Holding History

Royal Bank of Canada’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
4
– – ﹤0.01% 7741
2025
Q4 		$0 Hold
4
– – ﹤0.01% 7686
2025
Q3 		$0 Hold
4
– – ﹤0.01% 7566
2025
Q2 		$0 Sell
4
-18,000
-100% -$45.4K ﹤0.01% 7381
2025
Q1 		$51K Buy
18,004
+18,000
+450,000% +$70.7K ﹤0.01% 5569
2024
Q4 		$0 Hold
4
– – ﹤0.01% 7288
2024
Q3 		$0 Sell
4
-3
-43% -$8 ﹤0.01% 7508
2024
Q2 		$0 Hold
7
– – ﹤0.01% 7585
2024
Q1 		$0 Hold
7
– – ﹤0.01% 7654
2023
Q4 		$0 Sell
7
-11
-61% -$94 ﹤0.01% 7631
2023
Q3 		$0 Sell
18
-36
-67% -$272 ﹤0.01% 7653
2023
Q2 		$1K Buy
54
+41
+315% +$402 ﹤0.01% 7096
2023
Q1 		$0 Buy
13
+9
+225% +$197 ﹤0.01% 7527
2022
Q4 		$0 Sell
4
-683
-99% -$9.99K ﹤0.01% 7772
2022
Q3 		$11K Buy
687
+677
+6,770% +$20.6K ﹤0.01% 6399
2022
Q2 		$0 Buy
10
+4
+67% +$166 ﹤0.01% 7751
2022
Q1 		$0 Hold
6
– – ﹤0.01% 8047
2021
Q4 		$0 Sell
6
-21
-78% -$1.69K ﹤0.01% 7920
2021
Q3 		$3K Buy
+27
New +$2.84K ﹤0.01% 7280

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Royal Bank of Canada's VVOS Position: Q1 2026 in Review

Royal Bank of Canada held its Vivos Therapeutics (VVOS) position steady in Q1 2026 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7741.

Royal Bank of Canada first reported a position in VVOS in Q3 2021 and has held it in 19 quarters since. The position peaked at $51K in Q1 2025. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • Royal Bank of Canada held 4 shares of Vivos Therapeutics worth $0 as of Q1 2026.
  • Royal Bank of Canada left its Vivos Therapeutics share count unchanged in Q1 2026.
  • Vivos Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7741 holding.
  • Royal Bank of Canada first reported a position in Vivos Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Vivos Therapeutics position peaked at $51K in Q1 2025.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.